Healthcare

Global Immunoprotein Diagnostics Testing Market

April 20, 2022
ID: SR/HC-209
Format:Pdf
Pages:220

Global Immunoprotein Diagnostics Testing Market By Test Type (Complement System Protein Diagnostic Tests, Free Light Chain Diagnostics Tests, Haptoglobin Diagnostics Tests, Immunoglobulin Diagnostics Tests, Prealbumin Diagnostics Tests and C - reactive protein (CRP) Diagnostics Tests), By Application (Infection Disease Testing, Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing and Autoimmune Disease Testing), By Technology (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence, Immunoturbidity Assay and Immunoprotein Electrophoresis) and By Region (North America, Europe, Asia-Pacific, South America and The Middle East & Africa)-Global Forecast to 2028.

Description

Immunoprotein Diagnostic Testing Market Overview

The global Immunoprotein Diagnostic Testing market value was USD 11,136.40 million in 2021and; it is estimated to reach USD 19,387.19 million by 2028, with a CAGR of 7.2%from 2022 to 2028. An increase in the prevalence of chronic diseases has conducted to the growth of the immunoprotein diagnostic testing market. The expanded prevalence of chronic disorders, such as infectious conditions, cancer, cardiovascular disease, obesity, type 2 diabetes, and rheumatoid arthritis, has led to the growth of immunoprotein diagnostic testing products. Growing mortality due to such chronic diseases has led to an urgent demand for rapid diagnosis.

What is Immunoprotein Diagnostics Testing?

Immunoproteins are proteins like immunoglobulin, haptoglobin, and pre-albumin located in the blood and regulate the body’s immune responses. The testing of immunoproteins seeks to diagnose health conditions revealed by abnormal immunoprotein activity. The need within the global market for immunoprotein diagnostic testing has achieved momentum on account of key consequences in the field of medical treatment and diagnostics. Immunoproteins, in essence, refer to blood proteins that play an essential role in the functioning of the immune system.

Certain health conditions shown through immunoprotein activity have cardiovascular diseases, cancers, diabetes, obesity, rheumatoid arthritis and infectious conditions such as tuberculosis, malaria and AIDS.

Growth Drivers

Incidence & Prevalence of Infectious Diseases & Technical Developments

The evolution of the global immunoprotein diagnostic testing market is propelled by the increase in incidence & prevalence of infectious and chronic diseases, the rise in the geriatric population, and the growth in the need for early diagnostic services. In expansion, technological improvements in immunodiagnostic instruments and the introduction of novel automated techniques are set to increase the growth of the immunoprotein diagnostic testing market during the forecast years.

Opportunities

Continuous Research and Development Activities are Create Opportunities

The development of immunoprotein diagnostic testing products is expected to be driven by the high prevalence of rheumatoid arthritis, type 2 diabetes, obesity, cancer, cardiovascular disease, and infectious diseases. Raised rate of mortality owing to the prevalence of such chronic diseases has necessitated the requirement for getting in rapid diagnosis are, providing many opportunities in the global immunoprotein diagnostics testing market.

Restraints

Stringent Government Norms

Due to stringent government norms in several developed countries, the market encounters restrictions regarding permission for immunoprotein diagnostic testing methods and products. The availability of cheaper testing options due to the lax application of intellectual property rights in certain developing countries is also a major challenge for the market.

Pre Covid-19 Impact on Global Immunoprotein Diagnostics Testing Market

Before the covid-19 period, Technological advancements in immunoprotein diagnostics testing have led to the introduction of chemiluminescence assays. This technology aids in rapidly diagnosing chronic diseases with completely automated instruments and high throughput. Tests performed using chemiluminescence technology require a short processing time, usually just 30 to 45 minutes. This technology minimizes any interruption in the system’s workflow and helps onboard reagent capacity decrease turnaround time.

Covid-19 Impact on Global Immunoprotein Diagnostics Testing Market

The covid-19 pandemic has grown into a critical challenge for the healthcare industry, impacting the immunoprotein diagnostic testing market. During the pandemic, the market faces newer challenges, such as irregular supply chain events in manufacturing, producing and distributing diagnostic kits and assays worldwide. Besides, trade limitations and unavailability of human resources have further complicated the distribution of these test kits to consumers. However, the increasing demand for these products is reimbursed for this harmful impact during the covid-19 period.

Post Covid-19 Impact on Global Immunoprotein Diagnostics Testing Market

After the covid-19 period, pharmaceutical companies are given emergency-use licenses for diagnostic kits and assays to manage the pandemic. It has increased the demand for diagnostic testing in several countries, thereby propelling the growth of the immunoprotein diagnostic testing market. So after the pandemic, it is expected to grow positive for the key players in the market after the covid-19 explosion, owing to the increasing patient of covid-19 cases and the continued R&D concerning the potential use of immunoproteins for producing antibodies against the Covid-19 virus.

Test Type Segmental Analysis

Based on Test Type segmental Analysis, the global immunoprotein diagnostics testing market is segmented into Complement System Protein Diagnostic Tests, Free Light Chain Diagnostics Tests, Haptoglobin Diagnostics Tests, and Immunoglobulin Prealbumin and C – reactive protein (CRP) Diagnostics Tests. Immunoglobulin diagnostic tests have the largest revenue contributor, owing to growing incidences of auto-immune diseases worldwide. However, immunoglobulin tests are not useful in some circumstances, for example, during chemotherapy or radiation therapy and in ongoing blood transfusion or vaccinations.

Application Segmental Analysis

Based on Application segmental analysis, the global immunoprotein diagnostics testing market is segmented into Infection Disease Testing, Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing and Autoimmune Disease Testing. Infectious disease testing dominated the global immunoprotein diagnostics market due to the rising prevalence of chronic infectious diseases, such as HIV/AIDS. Fast diagnosis of infectious diseases in immunoprotein diagnostics has shown the growth of this segment. Enzyme-based immunoassays are considered rapid testing techniques for the detection of infectious diseases.

Technology Segmental Analysis

Based on segmental technology analysis, the global immunoprotein diagnostics testing market is segmented into Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence, Immunoturbidity Assay and Immunoprotein Electrophoresis. Enzyme-based Immunoassay (EIA) holds the largest market share in the global immunoprotein diagnostics market. It can be used as a diagnostic tool and a quality control tool in multiple companies and laboratories. Moreover, the major companies’ plurality has a comprehensive portfolio of analyzers with EIA technology. For example, Human Complement C3 ELISA Kit by Abcam operates this technology for diagnosis. These are some of the elements that can be attributed to the largest market share of EIA. Chemiluminescence assay is expected to show the highest growth over the forecast period due to its increased specificity, sensitivity and ability to catch antigens in human serum & plasma samples. Chemiluminescence assay is often described as an important tool for instant diagnosis of various diseases and is more accurate than fluorescence-based detection of labeled probes.

Regional Segmental Analysis

Based on regional segmental Analysis, the global immunoprotein diagnostics testing market is segmented into North America, Europe, Asia-Pacific, South America and The Middle East & Africa. The North American region immunoprotein diagnostic testing market accounted for the highest market share and is expected to keep this movement during the forecast period due to an increase in demand for quick diagnostic services to detect chronic diseases, continuous movements in preventive healthcare, and an increase in the number of drug abuse and allergy patients. The Asia-Pacific immunoprotein diagnostic testing market is anticipated to grow at the highest CAGR during the forecast period, owing to the number of patients suffering from chronic diseases and modifications in healthcare facilities in the region.

Competitors Analysis

The companies include Abbott Laboratories, Abcam PLC, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Enzo Life Science, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare, Thermos Fisher Scientific and other prominent players in the global immunoprotein diagnostics testing market.

Key Stakeholders

Market research and consulting firms
Industry associations
Immunoprotein Diagnostics Testing and Manufacturing Firms
Local Governments
Regulatory bodies
Suppliers
Retailers

Recent Developments

In May 2016- DiaSorin obtained the immunodiagnostic and molecular diagnostic products of Focus Diagnostics from Quest Diagnostics.
In June 2016- Ortho Clinical Diagnostics and Beckman Coulter, Inc. joined into a strategic collaboration for sales of Ortho’s VITROS 3600 Immunodiagnostic System and portfolio for infectious disorders in the U.S.
In April 2016- DiaSorin launched a new serological assay that can be used with the LIAISON Analyzer. The LIAISON H. pylori IgG product was established, which offers 90.4%- 98.4% positive results.

Scope of the Report

Report Attribute	Details
Revenue in 2021	USD 11,136.40 million
The revenue forecast in 2028	USD 19,387.19 million
Growth Rate	CAGR of 7.2 % from 2022 to 2028.
Historical data	2017 – 2020
Base Year	2021
Forecast period	2022 – 2028
Region covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key companies Profiled	The companies include Abbott Laboratories, Abcam PLC, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Enzo Life Science, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare and Thermos Fisher Scientific are the key players.

Market Modelling

By Test Type

Complement System Proteins Diagnostic Tests
Free Light Chain Diagnostics Tests
Haptoglobin Diagnostics Tests
Immunoglobulin Diagnostics Tests
Prealbumin Diagnostics Tests
C-Reactive Protein (CRP) Diagnostics Tests

By Application

By Technology

By Region

North America
Europe
Asia Pacific
South America
The Middle East & Africa

Table Of Contents

Methodology

Request Sample

Frequently Asked Questions (FAQ):

What are Immunoprotein Diagnostics Testing?

What is the market size of the global Immunoprotein Diagnostics Testing market?

The global Immunoprotein Diagnostic Testing market value was USD 11,136.40 million in 2021, and it is estimated to reach USD 19,387.19 million by 2028, with a CAGR of 7.2% from 2022 to 2028.

What are the growth elements of the global Immunoprotein Diagnostics Testing market?

The global immunoprotein diagnostic testing market is propelled by the increase in incidence & prevalence of infectious and chronic diseases, the rise in the geriatric population, and the growth in the need for early diagnostic services are the elements of the growth of growth the global Immunoprotein Diagnostic’s market.

What are the restraints in the global Immunoprotein Diagnostics Testing market?

Who are the key players in the global Immunoprotein Diagnostics Testing market?

The companies include Abbott Laboratories, Abcam PLC, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Enzo Life Science, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare and Thermos Fisher Scientific are the key players in the global Immunoprotein Diagnostic market.

Select License

We Accept

Analyst support

After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.

Customer satisfaction

According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.

Inimitable expertise

Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.

Assured quality

We have created a systematic way to determine standards and satisfy your expectations.

Instant delivery

Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.

Privacy policy

We understand the inkling of your privacy, we will never misuse your email address.

Custom research service

We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.

Quality & accuracy

We provide you with the accurate quality of the customized study of an exclusive report according to your research need.

Data visualization

As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.

Information security

We truly respect your privacy and promise to keep your personal and confidential information safe and secure.